Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Jun 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5073463013 | Prolonged-release vaginal delivery system (dose form) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5073464019 | Prolonged-release vaginal delivery system | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Prolonged-release vaginal delivery system | Is a | Vaginal dose form | true | Inferred relationship | Existential restriction modifier | ||
| Prolonged-release vaginal delivery system | Has basic dose form | System | true | Inferred relationship | Existential restriction modifier | ||
| Prolonged-release vaginal delivery system | Has dose form intended site | Vaginal | true | Inferred relationship | Existential restriction modifier | ||
| Prolonged-release vaginal delivery system | Has dose form release characteristic | Prolonged-release | true | Inferred relationship | Existential restriction modifier | ||
| Prolonged-release vaginal delivery system | Has dose form transformation | No transformation | true | Inferred relationship | Existential restriction modifier | ||
| Prolonged-release vaginal delivery system | Has dose form administration method | Insert | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely dinoprostone 10 milligram/1 each prolonged-release vaginal delivery system (clinical drug) | Has manufactured dose form | True | Prolonged-release vaginal delivery system | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR